Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients (Q41117363)
Jump to navigation
Jump to search
scientific article published on 5 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients |
scientific article published on 5 March 2015 |
Statements
1 reference
Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients (English)
1 reference
1 reference
1 reference
Pier Luigi Zinzani
1 reference
Giovanna Motta
1 reference
Monica Tani
1 reference
Nicola Cascavilla
1 reference
Alessandro Broccoli
1 reference
5 March 2015
1 reference
1 reference
Identifiers
1 reference